首页 > 最新文献

Reproductive biomedicine online最新文献

英文 中文
Inside Front Cover - Affiliations and First page of TOC 内部封面-附属机构和第一页的TOC
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2026-02-11 DOI: 10.1016/S1472-6483(26)00021-0
{"title":"Inside Front Cover - Affiliations and First page of TOC","authors":"","doi":"10.1016/S1472-6483(26)00021-0","DOIUrl":"10.1016/S1472-6483(26)00021-0","url":null,"abstract":"","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"52 2","pages":"Article 105480"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146189084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emotional experience of Danish men during fertility treatment: qualitative study on engagement, hope and loss 丹麦男性在生育治疗期间的情感体验:参与、希望和损失的定性研究。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2025-08-13 DOI: 10.1016/j.rbmo.2025.105217
Randi Sylvest , Lone Schmidt , Anja Pinborg , Søren Ziebe

Research question

How does being in fertility treatment affect men, and how can healthcare professionals better involve and support men throughout the process?

Design

Semi-structured qualitative interview study with 15 men (aged 31–47 years) undergoing fertility treatment. Four men had used donor semen. Six couples had experienced a pregnancy loss. Participants were recruited through fertility clinics, patient organizations and social media. Data were collected in 2023 and 2024 and analysed using qualitative content analysis.

Results

The following themes emerged from the interview data: involvement; hope (becoming a father and keeping positive); loss (psychological burden, control and masculinity); and lasting impact. Involvement and inclusion of men during fertility treatment were of critical importance. The men observed that this entails efforts from healthcare professionals to actively engage them and a recognition of their own responsibility in the process. The men saw the fertility journey as a shared and important issue. All participants expressed a profound sense of hope and motivation rooted in their aspiration to eventually become fathers. The men described experiencing the loss of dreams, hope, sense of masculinity and a sense of control. Experiencing infertility had a lasting effect on them, affecting them mentally, socially, sexually and financially, regardless of whether or not they ended up having children.

Conclusion

It is important that men are acknowledged and included in the fertility treatment process. Healthcare professionals need to recognize the effect of infertility on men aspiring to become fathers and their need to play a meaningful role during fertility treatment.
研究问题:接受生育治疗如何影响男性,医疗保健专业人员如何在整个过程中更好地参与和支持男性?设计:对15名接受生育治疗的男性(31-47岁)进行半结构化定性访谈研究。四名男子使用了捐赠的精液。有六对夫妇经历了流产。参与者是通过生育诊所、患者组织和社交媒体招募的。数据收集于2023年和2024年,采用定性内容分析法进行分析。结果:访谈数据显示以下主题:参与;希望(成为父亲,保持积极向上);丧失(心理负担、控制和男子气概);以及持久的影响。男性在生育治疗期间的参与和包容是至关重要的。这些男子指出,这需要医疗保健专业人员作出努力,使他们积极参与其中,并认识到他们在这一过程中的责任。男人们将生育之旅视为一个共同的重要问题。所有参与者都表达了深切的希望和动力,因为他们渴望最终成为父亲。这些男性描述了他们失去梦想、希望、男子气概和控制感的经历。不孕对她们产生了持久的影响,无论她们最终是否有孩子,都会在精神上、社交上、性上和经济上影响她们。结论:男性在生育治疗过程中得到认可和包容是非常重要的。医疗保健专业人员需要认识到不孕症对渴望成为父亲的男性的影响,以及他们需要在生育治疗中发挥有意义的作用。
{"title":"Emotional experience of Danish men during fertility treatment: qualitative study on engagement, hope and loss","authors":"Randi Sylvest ,&nbsp;Lone Schmidt ,&nbsp;Anja Pinborg ,&nbsp;Søren Ziebe","doi":"10.1016/j.rbmo.2025.105217","DOIUrl":"10.1016/j.rbmo.2025.105217","url":null,"abstract":"<div><h3>Research question</h3><div>How does being in fertility treatment affect men, and how can healthcare professionals better involve and support men throughout the process?</div></div><div><h3>Design</h3><div>Semi-structured qualitative interview study with 15 men (aged 31–47 years) undergoing fertility treatment. Four men had used donor semen. Six couples had experienced a pregnancy loss. Participants were recruited through fertility clinics, patient organizations and social media. Data were collected in 2023 and 2024 and analysed using qualitative content analysis.</div></div><div><h3>Results</h3><div>The following themes emerged from the interview data: involvement; hope (becoming a father and keeping positive); loss (psychological burden, control and masculinity); and lasting impact. Involvement and inclusion of men during fertility treatment were of critical importance. The men observed that this entails efforts from healthcare professionals to actively engage them and a recognition of their own responsibility in the process. The men saw the fertility journey as a shared and important issue. All participants expressed a profound sense of hope and motivation rooted in their aspiration to eventually become fathers. The men described experiencing the loss of dreams, hope, sense of masculinity and a sense of control. Experiencing infertility had a lasting effect on them, affecting them mentally, socially, sexually and financially, regardless of whether or not they ended up having children.</div></div><div><h3>Conclusion</h3><div>It is important that men are acknowledged and included in the fertility treatment process. Healthcare professionals need to recognize the effect of infertility on men aspiring to become fathers and their need to play a meaningful role during fertility treatment.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"52 2","pages":"Article 105217"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145834652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical efficacy of AdhesioRT-guided personalized embryo transfers: a prospective randomized controlled trial 粘连疗法引导的个体化胚胎移植的临床疗效:一项前瞻性随机对照试验
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2025-07-30 DOI: 10.1016/j.rbmo.2025.105174
Mélanie Chow-Shi-Yée , Eva Kadoch , Marie-Eve Stebenne , Artak Tadevosyan , Isaac-Jacques Kadoch

Research question

How effective is AdhesioRT in predicting endometrial receptivity, and how does its application affect clinical outcomes, such as pregnancy rates, in the context of personalized embryo transfers (pET)?

Design

AdhesioRT was employed to evaluate endometrial receptivity in a cohort of patients undergoing infertility assessment. The study included two endometrial biopsies during a substituted frozen embryo transfer cycle after 6 or 8 full days of progesterone treatment, where the gene expression of 10 specific biomarkers was analysed using quantitative reverse transcription polymerase chain reaction. Samples were categorized as receptive, partially receptive or non-receptive. The AdhesioRT group (n = 50) underwent pET guided by AdhesioRT recommendations, while the control group (n = 54) followed the standard clinic protocol.

Results

AdhesioRT identified a potential shift in the window of implantation (WOI) in 64% of the AdhesioRT group, yet pET led to a lower pregnancy rate compared with the control group (28% vs 61%). Transfers after 6 full days of progesterone treatment, as recommended by AdhesioRT, achieved a 59% pregnancy rate, whereas those with a suggested WOI shift (transfer at a different time point than after 6 full days of progesterone treatment) achieved a 20% pregnancy rate.

Conclusion

Surprisingly, AdhesioRT-guided embryo transfers did not lead to higher pregnancy rates, indicating that deviating from the standard transfer day (i.e. after 6 full days of progesterone treatment) may reduce the success of embryo implantation.
研究问题:在个性化胚胎移植(pET)的背景下,粘连ort在预测子宫内膜容受性方面的效果如何?它的应用如何影响临床结果,如妊娠率?在一组接受不孕症评估的患者中,采用粘连ort来评估子宫内膜容受性。该研究包括在孕激素治疗6或8天后的替代冷冻胚胎移植周期内进行两次子宫内膜活检,其中使用定量逆转录聚合酶链反应分析10种特定生物标志物的基因表达。样品被分类为可接受、部分可接受或不可接受。粘连ort组(n = 50)在粘连ort推荐的指导下进行pET,而对照组(n = 54)则遵循标准临床方案。结果黏附ort组有64%的患者发现了植入窗口(WOI)的潜在变化,而pET导致的妊娠率低于对照组(28%对61%)。根据粘连ort的建议,在孕酮治疗6天后转移,妊娠率达到59%,而建议WOI转移(在不同的时间点转移,而不是孕酮治疗6天后转移)的妊娠率为20%。令人惊讶的是,粘连移植引导下的胚胎移植并没有导致更高的妊娠率,这表明偏离标准移植日期(即孕激素治疗满6天后)可能会降低胚胎着床成功率。
{"title":"Clinical efficacy of AdhesioRT-guided personalized embryo transfers: a prospective randomized controlled trial","authors":"Mélanie Chow-Shi-Yée ,&nbsp;Eva Kadoch ,&nbsp;Marie-Eve Stebenne ,&nbsp;Artak Tadevosyan ,&nbsp;Isaac-Jacques Kadoch","doi":"10.1016/j.rbmo.2025.105174","DOIUrl":"10.1016/j.rbmo.2025.105174","url":null,"abstract":"<div><h3>Research question</h3><div>How effective is AdhesioRT in predicting endometrial receptivity, and how does its application affect clinical outcomes, such as pregnancy rates, in the context of personalized embryo transfers (pET)?</div></div><div><h3>Design</h3><div>AdhesioRT was employed to evaluate endometrial receptivity in a cohort of patients undergoing infertility assessment. The study included two endometrial biopsies during a substituted frozen embryo transfer cycle after 6 or 8 full days of progesterone treatment, where the gene expression of 10 specific biomarkers was analysed using quantitative reverse transcription polymerase chain reaction. Samples were categorized as receptive, partially receptive or non-receptive. The AdhesioRT group (<em>n</em> = 50) underwent pET guided by AdhesioRT recommendations, while the control group (<em>n</em> = 54) followed the standard clinic protocol.</div></div><div><h3>Results</h3><div>AdhesioRT identified a potential shift in the window of implantation (WOI) in 64% of the AdhesioRT group, yet pET led to a lower pregnancy rate compared with the control group (28% vs 61%). Transfers after 6 full days of progesterone treatment, as recommended by AdhesioRT, achieved a 59% pregnancy rate, whereas those with a suggested WOI shift (transfer at a different time point than after 6 full days of progesterone treatment) achieved a 20% pregnancy rate.</div></div><div><h3>Conclusion</h3><div>Surprisingly, AdhesioRT-guided embryo transfers did not lead to higher pregnancy rates, indicating that deviating from the standard transfer day (i.e. after 6 full days of progesterone treatment) may reduce the success of embryo implantation.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"52 2","pages":"Article 105174"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145808395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of vitamin D deficiency on phenotypes and IVF outcomes in PCOS: a prospective study 维生素D缺乏对PCOS患者表型和体外受精结果的影响:一项前瞻性研究
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2025-07-20 DOI: 10.1016/j.rbmo.2025.105170
Fei Zhao , Duo Wen , Lin Zeng , Lixue Chen , Rong Li , Hongbin Chi

Research question

Does vitamin D deficiency affect phenotypes and pregnancy outcomes in women with polycystic ovary syndrome (PCOS) who are undergoing IVF/intracytoplasmic sperm injection (ICSI)?

Design

This prospective cohort study recruited 725 infertile women with PCOS undergoing IVF/ICSI at the Reproductive Center of Peking University Third Hospital. The participants were divided into two groups according to the serum vitamin D concentration: the vitamin D deficiency group (serum 25(OH)D <20 ng/ml, n = 491) and vitamin D non-deficiency group (serum 25(OH)D ≥20 ng/ml, n = 234). Measurements were made of serum hormone concentrations and parameters relating to lipid and glucose metabolism. Pregnancy outcomes were clinical pregnancy and early miscarriage.

Results

Serum concentrations of anti-Müllerian hormone (P = 0.042), testosterone (P = 0.035) and androstenedione (P = 0.016) were higher in the vitamin D deficiency group than the non-deficiency group. Vitamin D deficiency was still associated with increased androstenedione concentrations after adjustment for confounders (regression coefficient –0.851, 95% confidence interval [95% CI] –1.661 to –0.042, P = 0.039). No significant difference was found in parameters of lipid and glucose metabolism or in clinical pregnancy and early miscarriage rates between two groups. There was no correlation between vitamin D deficiency and clinical pregnancy (odds ratio [OR] 1.193, 95% CI 0.852–1.671, P = 0.303) or early miscarriage (OR 1.360, 95% CI 0.668–2.767, P = 0.397).

Conclusions

Vitamin D deficiency is correlated with worse parameters, especially higher androstenedione concentrations in infertile women with PCOS. Vitamin D deficiency has no correlation with clinical pregnancy or early miscarriage in women with PCOS undergoing IVF/ICSI treatment.
研究问题:维生素D缺乏是否会影响接受体外受精/胞浆内单精子注射(ICSI)的多囊卵巢综合征(PCOS)患者的表型和妊娠结局?本前瞻性队列研究招募725名在北京大学第三医院生殖中心接受IVF/ICSI治疗的PCOS不孕妇女。根据受试者血清维生素D浓度分为两组:维生素D缺乏组(血清25(OH)D≥20 ng/ml, n = 491)和维生素D不缺乏组(血清25(OH)D≥20 ng/ml, n = 234)。测量血清激素浓度和血脂、葡萄糖代谢相关参数。妊娠结局为临床妊娠和早期流产。结果维生素D缺乏组血清抗勒氏激素(P = 0.042)、睾酮(P = 0.035)、雄烯二酮(P = 0.016)浓度均高于非维生素D缺乏组。调整混杂因素后,维生素D缺乏仍与雄烯二酮浓度升高相关(回归系数-0.851,95%可信区间[95% CI] -1.661至-0.042,P = 0.039)。两组患者血脂、糖代谢指标及临床妊娠、早期流产率均无显著差异。维生素D缺乏与临床妊娠(比值比[OR] 1.193, 95% CI 0.852-1.671, P = 0.303)或早期流产(比值比[OR] 1.360, 95% CI 0.668-2.767, P = 0.397)无相关性。结论维生素D缺乏与多囊卵巢综合征不孕妇女的各项指标恶化有关,尤其是雄烯二酮浓度升高。在接受IVF/ICSI治疗的PCOS患者中,维生素D缺乏与临床妊娠或早期流产无关。
{"title":"Impact of vitamin D deficiency on phenotypes and IVF outcomes in PCOS: a prospective study","authors":"Fei Zhao ,&nbsp;Duo Wen ,&nbsp;Lin Zeng ,&nbsp;Lixue Chen ,&nbsp;Rong Li ,&nbsp;Hongbin Chi","doi":"10.1016/j.rbmo.2025.105170","DOIUrl":"10.1016/j.rbmo.2025.105170","url":null,"abstract":"<div><h3>Research question</h3><div>Does vitamin D deficiency affect phenotypes and pregnancy outcomes in women with polycystic ovary syndrome (PCOS) who are undergoing IVF/intracytoplasmic sperm injection (ICSI)?</div></div><div><h3>Design</h3><div>This prospective cohort study recruited 725 infertile women with PCOS undergoing IVF/ICSI at the Reproductive Center of Peking University Third Hospital. The participants were divided into two groups according to the serum vitamin D concentration: the vitamin D deficiency group (serum 25(OH)D &lt;20 ng/ml, <em>n</em> = 491) and vitamin D non-deficiency group (serum 25(OH)D ≥20 ng/ml, <em>n</em> = 234). Measurements were made of serum hormone concentrations and parameters relating to lipid and glucose metabolism. Pregnancy outcomes were clinical pregnancy and early miscarriage.</div></div><div><h3>Results</h3><div>Serum concentrations of anti-Müllerian hormone (<em>P</em> = 0.042), testosterone (<em>P</em> = 0.035) and androstenedione (<em>P</em> = 0.016) were higher in the vitamin D deficiency group than the non-deficiency group. Vitamin D deficiency was still associated with increased androstenedione concentrations after adjustment for confounders (regression coefficient –0.851, 95% confidence interval [95% CI] –1.661 to –0.042, <em>P</em> = 0.039). No significant difference was found in parameters of lipid and glucose metabolism or in clinical pregnancy and early miscarriage rates between two groups. There was no correlation between vitamin D deficiency and clinical pregnancy (odds ratio [OR] 1.193, 95% CI 0.852–1.671, <em>P</em> = 0.303) or early miscarriage (OR 1.360, 95% CI 0.668–2.767, <em>P</em> = 0.397).</div></div><div><h3>Conclusions</h3><div>Vitamin D deficiency is correlated with worse parameters, especially higher androstenedione concentrations in infertile women with PCOS. Vitamin D deficiency has no correlation with clinical pregnancy or early miscarriage in women with PCOS undergoing IVF/ICSI treatment.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"52 2","pages":"Article 105170"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145927750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mid-luteal serum progesterone concentrations in modified natural cycles for embryo transfer: a prospective blinded study 胚胎移植改良自然周期中黄体中期血清黄体酮浓度:一项前瞻性盲法研究。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2025-07-22 DOI: 10.1016/j.rbmo.2025.105171
Elena Labarta , Cristina Rodríguez-Varela , Carmina Vidal , Jakob Doblinger , Pilar Alamá , Alicia Marzal , Fabio Cruz , Juan Giles , José Bellver , Pep Romero , Inés Olmo , Víctor H. Gómez , José Remohí , Stefania Paolelli , Ernesto Bosch

Research question

Does mid-luteal serum progesterone concentration influence pregnancy outcomes in modified natural cycle frozen embryo transfer (mNC-FET) with ovulation triggering and luteal phase support (LPS)?

Design

This prospective, blinded, single-centre cohort study was conducted at IVIRMA Valencia (Spain) between February 2020 and June 2021. A total of 241 infertile patients under 50 years old, with body mass index (BMI) <40 kg/m2, undergoing mNC-FET were included. Ovulation was triggered with recombinant human chorionic gonadotrophin when the dominant follicle measured ≥16 mm and endometrial thickness was >6.5 mm. LPS was provided with micronized vaginal progesterone 200 mg every 12 h. Serum progesterone was measured within 2 h of embryo transfer, and results were blinded until study completion.

Results

Mean serum progesterone on embryo transfer day was 26.2 ± 9.0 ng/ml, with 99% of patients exceeding the clinically relevant threshold (>10 ng/ml). Participants were stratified into quartiles by progesterone concentration, with no significant differences in ongoing pregnancy rates: Q1 (<20.2 ng/ml), 56.7%; Q2 (20.2–24.8 ng/ml), 47.5%; Q3 (24.9–31.1 ng/ml), 51.7%; Q4 (>31.1 ng/ml), 48.3% (P = 0.74). Live birth rates were also comparable (P = 0.66). In multivariable logistic regression, mid-luteal serum progesterone was not significantly associated with ongoing pregnancy (odds ratio 0.86, 95% CI 0.40–1.85; P = 0.70) after adjusting for clinical covariates. Female age, oocyte age, BMI, number of previous transfers, embryos transferred, embryo quality, and oocyte origin were also unrelated to pregnancy probability.

Conclusions

In mNC-FET cycles with HCG triggering and LPS, mid-luteal serum progesterone concentrations were consistently adequate and not associated with pregnancy outcomes. Routine progesterone monitoring appears unnecessary in this setting.
研究问题:黄体中期血清黄体酮浓度是否影响具有促排卵和黄体期支持(LPS)的改良自然周期冷冻胚胎移植(mNC-FET)的妊娠结局?设计:这项前瞻性、盲法、单中心队列研究于2020年2月至2021年6月在西班牙瓦伦西亚IVIRMA进行。本研究共纳入241例年龄在50岁以下、体重指数(BMI)为2、接受mNC-FET治疗的不孕症患者。重组人绒毛膜促性腺激素在优势卵泡≥16mm,子宫内膜厚度为>6.5 mm时触发排卵。每12 h给LPS注射阴道孕酮200 mg,在胚胎移植后2 h内测定血清孕酮水平,并对结果进行盲法处理直至研究完成。结果:胚胎移植当天血清黄体酮平均值为26.2±9.0 ng/ml, 99%的患者超过临床相关阈值(10 ng/ml)。根据孕酮浓度将参与者分为四分位数,持续妊娠率无显著差异:Q1 (31.1 ng/ml), 48.3% (P = 0.74)。活产率也具有可比性(P = 0.66)。在多变量logistic回归中,调整临床协变量后,黄体中期血清黄体酮与持续妊娠无显著相关(优势比0.86,95% CI 0.40-1.85; P = 0.70)。女性年龄、卵母细胞年龄、BMI、既往移植次数、移植胚胎、胚胎质量和卵母细胞来源也与妊娠概率无关。结论:在HCG触发和LPS的mNC-FET周期中,黄体中期血清黄体酮浓度始终足够,与妊娠结局无关。在这种情况下,常规的黄体酮监测似乎是不必要的。
{"title":"Mid-luteal serum progesterone concentrations in modified natural cycles for embryo transfer: a prospective blinded study","authors":"Elena Labarta ,&nbsp;Cristina Rodríguez-Varela ,&nbsp;Carmina Vidal ,&nbsp;Jakob Doblinger ,&nbsp;Pilar Alamá ,&nbsp;Alicia Marzal ,&nbsp;Fabio Cruz ,&nbsp;Juan Giles ,&nbsp;José Bellver ,&nbsp;Pep Romero ,&nbsp;Inés Olmo ,&nbsp;Víctor H. Gómez ,&nbsp;José Remohí ,&nbsp;Stefania Paolelli ,&nbsp;Ernesto Bosch","doi":"10.1016/j.rbmo.2025.105171","DOIUrl":"10.1016/j.rbmo.2025.105171","url":null,"abstract":"<div><h3>Research question</h3><div>Does mid-luteal serum progesterone concentration influence pregnancy outcomes in modified natural cycle frozen embryo transfer (mNC-FET) with ovulation triggering and luteal phase support (LPS)?</div></div><div><h3>Design</h3><div>This prospective, blinded, single-centre cohort study was conducted at IVIRMA Valencia (Spain) between February 2020 and June 2021. A total of 241 infertile patients under 50 years old, with body mass index (BMI) &lt;40 kg/m<sup>2</sup>, undergoing mNC-FET were included. Ovulation was triggered with recombinant human chorionic gonadotrophin when the dominant follicle measured ≥16 mm and endometrial thickness was &gt;6.5 mm. LPS was provided with micronized vaginal progesterone 200 mg every 12 h. Serum progesterone was measured within 2 h of embryo transfer, and results were blinded until study completion.</div></div><div><h3>Results</h3><div>Mean serum progesterone on embryo transfer day was 26.2 ± 9.0 ng/ml, with 99% of patients exceeding the clinically relevant threshold (&gt;10 ng/ml). Participants were stratified into quartiles by progesterone concentration, with no significant differences in ongoing pregnancy rates: Q1 (&lt;20.2 ng/ml), 56.7%; Q2 (20.2–24.8 ng/ml), 47.5%; Q3 (24.9–31.1 ng/ml), 51.7%; Q4 (&gt;31.1 ng/ml), 48.3% (<em>P</em> = 0.74). Live birth rates were also comparable (<em>P</em> = 0.66). In multivariable logistic regression, mid-luteal serum progesterone was not significantly associated with ongoing pregnancy (odds ratio 0.86, 95% CI 0.40–1.85; <em>P</em> = 0.70) after adjusting for clinical covariates. Female age, oocyte age, BMI, number of previous transfers, embryos transferred, embryo quality, and oocyte origin were also unrelated to pregnancy probability.</div></div><div><h3>Conclusions</h3><div>In mNC-FET cycles with HCG triggering and LPS, mid-luteal serum progesterone concentrations were consistently adequate and not associated with pregnancy outcomes. Routine progesterone monitoring appears unnecessary in this setting.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"52 2","pages":"Article 105171"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145496225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron deposition in ovarian endometrioma evaluated by magnetic resonance imaging R2* non-invasively 无创R2*磁共振成像评价卵巢子宫内膜瘤中的铁沉积
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2025-04-24 DOI: 10.1016/j.rbmo.2025.105024
Ping Zhang , Yaan Song , Meixia Su , Ying Lin , Yuxuan He , Xiaoxuan Liu , Namei Wu , Yiqing Lin , Zihan Wang , Ming Yuan , Yan Zhang , Guoyun Wang

Research question

Is surgery effective in decreasing iron deposition in the ovarian tissue surrounding an ovarian endometrioma?

Design

This cohort study was conducted in China between July 2023 and April 2024. Seventy-nine patients with ovarian endometriomas and 45 controls with other ovarian cyst types were enrolled. Magnetic resonance imaging using a relaxation sequence (MRI-R2*) has been proven to be a reliable method for detecting iron deposition. All participants underwent MRI-R2* preoperatively to detect the presence of iron in ovarian tissue, before surgical ovarian cystectomy. Additionally, patients with ovarian endometriosis underwent MRI-R2* 3 months after surgery. The end points were changes in iron content, as reflected by the R2* value of ovarian tissue, surrounding an ovarian endometrioma.

Results

The preoperative R2* value of the affected-side ovarian tissue in the ovarian endometriosis group was significantly higher than that in the control group (27.00 [22.50–32.25] Hz versus 23.00 [13.50–26.36] Hz; P = 0.012). In the ovarian endometriosis group, the affected-side ovarian tissue had higher R2* values than the intact side ovarian tissue before (27.00 [22.50–32.25] Hz versus 19.19 [14.43–24.12] Hz; P = 0.019) and after (27.13 [21.80–31.50] Hz versus 21.96 [19.00–27.53] Hz; P = 0.015) surgery. No significant changes were observed in the R2* values of the affected-side ovarian tissue after surgery.

Conclusions

In patients with ovarian endometriomas, the affected-side ovarian tissue demonstrated no reduction in iron content within 3 months of ovarian cystectomy. Cystectomy alone is inadequate for complete elimination of local iron deposition. Serial MRI-R2* monitoring could serve as an objective modality for assessing postoperative iron deposition dynamics.
研究问题:手术是否能有效减少卵巢子宫内膜异位瘤周围卵巢组织中的铁沉积?本队列研究于2023年7月至2024年4月在中国进行。79例卵巢子宫内膜异位瘤患者和45例其他类型卵巢囊肿患者被纳入研究。使用弛豫序列(MRI-R2*)的磁共振成像已被证明是检测铁沉积的可靠方法。所有参与者术前接受MRI-R2*检测卵巢组织中铁的存在,然后进行卵巢囊肿切除术。此外,卵巢子宫内膜异位症患者术后3个月复查MRI-R2*。终点是铁含量的变化,由卵巢子宫内膜瘤周围组织的R2*值反映。结果卵巢子宫内膜异位症组受累侧卵巢组织术前R2*值明显高于对照组(27.00 [22.50 ~ 32.25]Hz vs . 23.00 [13.50 ~ 26.36] Hz, P = 0.012)。在卵巢子宫内膜异位症组中,手术前(27.00 [22.50-32.25]Hz vs . 19.19 [14.43-24.12] Hz, P = 0.019)和手术后(27.13 [21.80-31.50]Hz vs . 21.96 [19.00-27.53] Hz, P = 0.015)患侧卵巢组织的R2*值高于完整侧卵巢组织。术后受累侧卵巢组织R2*值未见明显变化。结论卵巢子宫内膜异位瘤患者在卵巢囊肿切除术后3个月内,受累侧卵巢组织铁含量未降低。单纯膀胱切除术不足以完全消除局部铁沉积。连续MRI-R2*监测可作为评估术后铁沉积动态的客观方式。
{"title":"Iron deposition in ovarian endometrioma evaluated by magnetic resonance imaging R2* non-invasively","authors":"Ping Zhang ,&nbsp;Yaan Song ,&nbsp;Meixia Su ,&nbsp;Ying Lin ,&nbsp;Yuxuan He ,&nbsp;Xiaoxuan Liu ,&nbsp;Namei Wu ,&nbsp;Yiqing Lin ,&nbsp;Zihan Wang ,&nbsp;Ming Yuan ,&nbsp;Yan Zhang ,&nbsp;Guoyun Wang","doi":"10.1016/j.rbmo.2025.105024","DOIUrl":"10.1016/j.rbmo.2025.105024","url":null,"abstract":"<div><h3>Research question</h3><div>Is surgery effective in decreasing iron deposition in the ovarian tissue surrounding an ovarian endometrioma?</div></div><div><h3>Design</h3><div>This cohort study was conducted in China between July 2023 and April 2024. Seventy-nine patients with ovarian endometriomas and 45 controls with other ovarian cyst types were enrolled. Magnetic resonance imaging using a relaxation sequence (MRI-R2*) has been proven to be a reliable method for detecting iron deposition. All participants underwent MRI-R2* preoperatively to detect the presence of iron in ovarian tissue, before surgical ovarian cystectomy. Additionally, patients with ovarian endometriosis underwent MRI-R2* 3 months after surgery. The end points were changes in iron content, as reflected by the R2* value of ovarian tissue, surrounding an ovarian endometrioma.</div></div><div><h3>Results</h3><div>The preoperative R2* value of the affected-side ovarian tissue in the ovarian endometriosis group was significantly higher than that in the control group (27.00 [22.50–32.25] Hz versus 23.00 [13.50–26.36] Hz; <em>P</em> = 0.012). In the ovarian endometriosis group, the affected-side ovarian tissue had higher R2* values than the intact side ovarian tissue before (27.00 [22.50–32.25] Hz versus 19.19 [14.43–24.12] Hz; <em>P</em> = 0.019) and after (27.13 [21.80–31.50] Hz versus 21.96 [19.00–27.53] Hz; <em>P</em> = 0.015) surgery. No significant changes were observed in the R2* values of the affected-side ovarian tissue after surgery.</div></div><div><h3>Conclusions</h3><div>In patients with ovarian endometriomas, the affected-side ovarian tissue demonstrated no reduction in iron content within 3 months of ovarian cystectomy. Cystectomy alone is inadequate for complete elimination of local iron deposition. Serial MRI-R2* monitoring could serve as an objective modality for assessing postoperative iron deposition dynamics.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"52 2","pages":"Article 105024"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145927741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyaluronan-enriched transfer media in PGT-A cycles: a stratified cohort analysis PGT-A循环中富含透明质酸的转移介质:分层队列分析
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-02-01 Epub Date: 2025-09-08 DOI: 10.1016/j.rbmo.2025.105235
Pierfrancesco Greco , Flavia Costanzi , Ilaria Listorti , Maria Teresa Varricchio , Katarzyna Litwicka , Cristiana Arrivi , Cecilia Mencacci , Ermanno Greco , Alessandro Colasante

Research question

Can hyaluronan-enriched transfer medium (HETM) improve reproductive outcomes in frozen single euploid blastocyst transfers after preimplantation genetic testing for aneuploidy (PGT-A)?

Design

Retrospective analysis of 445 patients (549 cycles), who had PGT-A embryo transfers that used HETM (EmbryoGlue) versus standard medium. Subgroup analyses were conducted based on blastocyst morphology, maternal age and previous implantation failure.

Results

No significant differences were found between HETM and control groups in the main reproductive outcomes, including positive HCG rates (72.27% versus 70.23%, P = 0.648), clinical pregnancy (80.23% versus 84.11%, P = 0.440), live birth rates (66.28% versus 72.85%, P = 0.237), and miscarriage rates (13.95% and 11.26%, P = 0.404).
Subgroup analyses by blastocyst cohort quality, maternal age and previous implantation failure showed no statistically significant benefit of HETM. On transfers of poor morphology (C-grade) blastocysts, HETM was associated with a significantly higher HCG-positive rate (79.17% for HETM versus 52.94% for the control group, P = 0.021), but this did not translate into improved clinical pregnancy (52.63% HETM versus 68.89% control group; P = 0.231) or live birth rates (47.37% HETM versus 62.22% control group; P = 0.284).

Conclusions

HETM did not provide a significant advantage in reproductive outcomes after single euploid blastocyst transfer. Its limited benefit in specific subgroups, such as poor morphology embryos, warrants cautious use and further research.
研究问题:植入前非整倍体基因检测(PGT-A)后,富含透明质酸的移植培养基(HETM)能否改善冷冻单整倍体囊胚移植的生殖结果?设计回顾性分析445例(549个周期)使用HETM (embryogue)和标准培养基进行PGT-A胚胎移植的患者。根据囊胚形态、产妇年龄和既往着床失败情况进行亚组分析。结果HETM组与对照组在HCG阳性率(72.27%比70.23%,P = 0.648)、临床妊娠率(80.23%比84.11%,P = 0.440)、活产率(66.28%比72.85%,P = 0.237)、流产率(13.95%比11.26%,P = 0.404)等主要生殖结局方面差异均无统计学意义。根据胚泡队列质量、产妇年龄和既往着床失败进行的亚组分析显示,HETM没有统计学意义上的显著益处。在形态学差的(c级)囊囊移植中,HETM与较高的hcg阳性率相关(HETM组为79.17%,对照组为52.94%,P = 0.021),但这并没有转化为改善临床妊娠(52.63% HETM组为68.89%,P = 0.231)或活产率(47.37% HETM组为62.22%,P = 0.284)。结论shetm对单整倍体囊胚移植后的生殖结局没有明显的优势。它在特定亚群(如形态学差的胚胎)中的有限益处值得谨慎使用和进一步研究。
{"title":"Hyaluronan-enriched transfer media in PGT-A cycles: a stratified cohort analysis","authors":"Pierfrancesco Greco ,&nbsp;Flavia Costanzi ,&nbsp;Ilaria Listorti ,&nbsp;Maria Teresa Varricchio ,&nbsp;Katarzyna Litwicka ,&nbsp;Cristiana Arrivi ,&nbsp;Cecilia Mencacci ,&nbsp;Ermanno Greco ,&nbsp;Alessandro Colasante","doi":"10.1016/j.rbmo.2025.105235","DOIUrl":"10.1016/j.rbmo.2025.105235","url":null,"abstract":"<div><h3>Research question</h3><div>Can hyaluronan-enriched transfer medium (HETM) improve reproductive outcomes in frozen single euploid blastocyst transfers after preimplantation genetic testing for aneuploidy (PGT-A)?</div></div><div><h3>Design</h3><div>Retrospective analysis of 445 patients (549 cycles), who had PGT-A embryo transfers that used HETM (EmbryoGlue) versus standard medium. Subgroup analyses were conducted based on blastocyst morphology, maternal age and previous implantation failure.</div></div><div><h3>Results</h3><div>No significant differences were found between HETM and control groups in the main reproductive outcomes, including positive HCG rates (72.27% versus 70.23%, <em>P</em> = 0.648), clinical pregnancy (80.23% versus 84.11%, <em>P</em> = 0.440), live birth rates (66.28% versus 72.85%, <em>P</em> = 0.237), and miscarriage rates (13.95% and 11.26%, <em>P</em> = 0.404).</div><div>Subgroup analyses by blastocyst cohort quality, maternal age and previous implantation failure showed no statistically significant benefit of HETM. On transfers of poor morphology (C-grade) blastocysts, HETM was associated with a significantly higher HCG-positive rate (79.17% for HETM versus 52.94% for the control group, <em>P</em> = 0.021), but this did not translate into improved clinical pregnancy (52.63% HETM versus 68.89% control group; <em>P</em> = 0.231) or live birth rates (47.37% HETM versus 62.22% control group; <em>P</em> = 0.284).</div></div><div><h3>Conclusions</h3><div>HETM did not provide a significant advantage in reproductive outcomes after single euploid blastocyst transfer. Its limited benefit in specific subgroups, such as poor morphology embryos, warrants cautious use and further research.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"52 2","pages":"Article 105235"},"PeriodicalIF":3.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145885634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preimplantation genetic testing for meiotic aneuploidy in trophectoderm biopsies - is it time to change our approach? 营养外胚层活检中减数分裂非整倍体的着床前基因检测-是时候改变我们的方法了吗?
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-28 DOI: 10.1016/j.rbmo.2026.105504
Alan H Handyside, Jakub Horak, Carles Gimenez, Tristan Hardy, Baharak Mohammadi, Michael C Summers

Direct evidence from live cell imaging and single-cell sequencing of disaggregated cells that mitotic abnormalities continue to occur in the trophectoderm at the blastocyst stage, resulting in clones of aneuploid cells, has important implications for preimplantation genetic testing (PGT) for aneuploidies. Here we argue that, to improve accuracy and minimize the deselection of potentially viable embryos with only mitotic aneuploidies of unknown clinical significance, the use of methods that, up until now, have only been used for PGT for monogenic/single-gene defects could provide the answer. Genome-wide single-nucleotide polymorphism parental haplotyping (karyomapping) is a universal linkage-based method for tracking the inheritance of disease genes. However, the same method can be used for molecular karyotyping to identify meiotic trisomies and monosomies or segmental deletions by the presence of dual parental haplotypes, or absence of parental haplotypes, respectively. Combined with parental intensity analysis to detect mitotic aneuploidies with normal biparental inheritance, this allows meiotic and mitotic, whole and segmental chromosome aneuploidies to be identified. This provides the opportunity to prioritize the deselection of embryos with meiotic aneuploidies affecting the whole embryo while considering those with only mitotic aneuploidies for transfer, with appropriate genetic counselling.

来自活细胞成像和分裂细胞单细胞测序的直接证据表明,胚泡期滋养外胚层有丝分裂异常继续发生,导致非整倍体细胞的克隆,这对非整倍体的着床前遗传学检测(PGT)具有重要意义。在这里,我们认为,为了提高准确性并最大限度地减少只有临床意义未知的有丝分裂非整倍体的潜在存活胚胎的失选,使用迄今为止仅用于单基因/单基因缺陷的PGT方法可以提供答案。全基因组单核苷酸多态性亲本单倍型是一种基于连锁的疾病基因遗传追踪方法。然而,同样的方法可以用于分子核型鉴定减数分裂三体和单体或片段缺失,分别通过双亲本单倍型的存在或亲本单倍型的缺失。结合亲代强度分析来检测具有正常双亲代遗传的有丝分裂非整倍体,这允许鉴定减数分裂和有丝分裂,全染色体和节段染色体非整倍体。这提供了一个机会,优先选择影响整个胚胎的减数分裂非整倍体的胚胎,同时考虑那些只有有丝分裂非整倍体的胚胎进行转移,并提供适当的遗传咨询。
{"title":"Preimplantation genetic testing for meiotic aneuploidy in trophectoderm biopsies - is it time to change our approach?","authors":"Alan H Handyside, Jakub Horak, Carles Gimenez, Tristan Hardy, Baharak Mohammadi, Michael C Summers","doi":"10.1016/j.rbmo.2026.105504","DOIUrl":"https://doi.org/10.1016/j.rbmo.2026.105504","url":null,"abstract":"<p><p>Direct evidence from live cell imaging and single-cell sequencing of disaggregated cells that mitotic abnormalities continue to occur in the trophectoderm at the blastocyst stage, resulting in clones of aneuploid cells, has important implications for preimplantation genetic testing (PGT) for aneuploidies. Here we argue that, to improve accuracy and minimize the deselection of potentially viable embryos with only mitotic aneuploidies of unknown clinical significance, the use of methods that, up until now, have only been used for PGT for monogenic/single-gene defects could provide the answer. Genome-wide single-nucleotide polymorphism parental haplotyping (karyomapping) is a universal linkage-based method for tracking the inheritance of disease genes. However, the same method can be used for molecular karyotyping to identify meiotic trisomies and monosomies or segmental deletions by the presence of dual parental haplotypes, or absence of parental haplotypes, respectively. Combined with parental intensity analysis to detect mitotic aneuploidies with normal biparental inheritance, this allows meiotic and mitotic, whole and segmental chromosome aneuploidies to be identified. This provides the opportunity to prioritize the deselection of embryos with meiotic aneuploidies affecting the whole embryo while considering those with only mitotic aneuploidies for transfer, with appropriate genetic counselling.</p>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"52 5","pages":"105504"},"PeriodicalIF":3.5,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147499886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the concordance between AI-based and conventional embryo selection: implications for clinical decision-making. 评估人工智能与传统胚胎选择的一致性:对临床决策的影响。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-23 DOI: 10.1016/j.rbmo.2026.105502
Piotr Wygocki, Tomasz Gilewicz, Paweł Pawlik, Michał Siennicki, Michał Brzozowski, Joanna Kuśmierczyk-Kubiak, Urszula Sankowska, Robert Milewski, Agnieszka Chmielowska, Marta Kordalewska, Małgorzata Różańska, Waldemar Kuczyński, Bartłomiej Wojtasik, Piotr Sankowski, Juergen Liebermann

Research question: Can artificial intelligence (AI) standardize embryo scoring, and help embryologists to identify embryos with the highest likelihood of pregnancy and live birth?

Design: Multicentre, retrospective, head-to-head analysis across six centres in five countries. An embryo selection algorithm (ESA) and 20 embryologists of varying seniority independently selected the implanting (i.e. 'best') embryo from 1681 pairs (1237 pairs with biochemical pregnancy; 444 pairs with live births), with each pair comprising one embryo with a positive outcome and one embryo with a negative outcome. Accuracy was computed for the ESA and for the embryologists; differences were assessed using McNemar's test.

Results: The accuracy of the ESA was 70.1%. The accuracy of individual embryologists ranged from 64.2% to 68.9% (mean value for embryologists 67.7%), and the accuracy of the expert committee (i.e. majority vote across the 20 embryologists) was 69.5%. McNemar's test indicated a significant advantage for the ESA compared with 14 of 20 embryologists, and the mean value for embryologists (P < 0.05), but no significant difference between the ESA and the remaining six embryologists or the expert committee.

Conclusions: The ESA achieved higher accuracy than most individual embryologists and the mean value for embryologists, supporting its potential as a standardized adjunct to expert judgement. Confirmation of effectiveness and generalizability requires adequately powered, prospective multicentre trials.

研究问题:人工智能(AI)能否标准化胚胎评分,并帮助胚胎学家识别最有可能怀孕和活产的胚胎?设计:在5个国家的6个中心进行多中心、回顾性、正面分析。胚胎选择算法(ESA)和20名不同资历的胚胎学家独立选择了植入(即。“最佳”)胚胎来自1681对(1237对生化妊娠,444对活产),每对包括一个阳性结果的胚胎和一个阴性结果的胚胎。为ESA和胚胎学家计算了精度;使用McNemar试验评估差异。结果:ESA的准确率为70.1%。个体胚胎学家的准确率从64.2%到68.9%(胚胎学家的平均值为67.7%),专家委员会(即20名胚胎学家的多数投票)的准确率为69.5%。McNemar的测试表明,ESA与20名胚胎学家中的14名相比具有显著优势,与胚胎学家的平均值相比具有显著优势(P < 0.05),但ESA与其余6名胚胎学家或专家委员会之间没有显著差异。结论:ESA比大多数个体胚胎学家和胚胎学家的平均值具有更高的准确性,支持其作为专家判断的标准化辅助手段的潜力。确认有效性和普遍性需要充分有力的前瞻性多中心试验。
{"title":"Evaluating the concordance between AI-based and conventional embryo selection: implications for clinical decision-making.","authors":"Piotr Wygocki, Tomasz Gilewicz, Paweł Pawlik, Michał Siennicki, Michał Brzozowski, Joanna Kuśmierczyk-Kubiak, Urszula Sankowska, Robert Milewski, Agnieszka Chmielowska, Marta Kordalewska, Małgorzata Różańska, Waldemar Kuczyński, Bartłomiej Wojtasik, Piotr Sankowski, Juergen Liebermann","doi":"10.1016/j.rbmo.2026.105502","DOIUrl":"https://doi.org/10.1016/j.rbmo.2026.105502","url":null,"abstract":"<p><strong>Research question: </strong>Can artificial intelligence (AI) standardize embryo scoring, and help embryologists to identify embryos with the highest likelihood of pregnancy and live birth?</p><p><strong>Design: </strong>Multicentre, retrospective, head-to-head analysis across six centres in five countries. An embryo selection algorithm (ESA) and 20 embryologists of varying seniority independently selected the implanting (i.e. 'best') embryo from 1681 pairs (1237 pairs with biochemical pregnancy; 444 pairs with live births), with each pair comprising one embryo with a positive outcome and one embryo with a negative outcome. Accuracy was computed for the ESA and for the embryologists; differences were assessed using McNemar's test.</p><p><strong>Results: </strong>The accuracy of the ESA was 70.1%. The accuracy of individual embryologists ranged from 64.2% to 68.9% (mean value for embryologists 67.7%), and the accuracy of the expert committee (i.e. majority vote across the 20 embryologists) was 69.5%. McNemar's test indicated a significant advantage for the ESA compared with 14 of 20 embryologists, and the mean value for embryologists (P < 0.05), but no significant difference between the ESA and the remaining six embryologists or the expert committee.</p><p><strong>Conclusions: </strong>The ESA achieved higher accuracy than most individual embryologists and the mean value for embryologists, supporting its potential as a standardized adjunct to expert judgement. Confirmation of effectiveness and generalizability requires adequately powered, prospective multicentre trials.</p>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":" ","pages":"105502"},"PeriodicalIF":3.5,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147459497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The new vitrification and warming protocols: when rapid is not really rapid. 新的玻璃化和升温协议:当快速不是真正的快速时。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-18 DOI: 10.1016/j.rbmo.2026.105497
Alessandro Bartolacci, Lodovico Parmegiani, Gabor Vajta

New vitrification and warming protocols have recently been developed to shorten procedure times and reduce exposure to potentially harmful cryoprotectants (CPA). These protocols are often described as 'rapid' or 'ultra-fast' but these terms are misleading. Speed-related terminology in cryopreservation has historically referred to cooling and warming rates, and not the length of time samples spend in solutions. Using 'rapid' warming or 'ultra-fast' vitrification implies that the speed at which a sample goes from cryogenic temperature (-196°C) to body temperature (37°C) or vice versa has been increased. However, most newly proposed protocols shorten exposure times or eliminate steps without altering thermal kinetics or CPA uptake and removal dynamics. Calling them 'rapid' causes confusion and may mislead practitioners. Instead, protocols that only reduce time in CPA solutions or omit steps should be called 'shortened protocols'. Precise language is crucial to ensure clear communication, accurate data interpretation and proper clinical practice. Only protocols that physically speed up cooling or warming rates should be labelled 'rapid' or 'ultra-fast'.

最近开发了新的玻璃化和升温方案,以缩短操作时间并减少暴露于潜在有害的冷冻保护剂(CPA)。这些协议通常被描述为“快速”或“超快速”,但这些术语具有误导性。在低温保存中,与速度相关的术语历来是指冷却和升温速率,而不是样品在溶液中花费的时间长度。使用“快速”升温或“超快速”玻璃化意味着样品从低温(-196°C)到体温(37°C)或反之亦然的速度已经增加。然而,大多数新提出的方案在不改变热动力学或CPA摄取和去除动力学的情况下缩短了暴露时间或消除了步骤。称它们为“快速”会引起混淆,并可能误导从业者。相反,只减少CPA解决方案的时间或省略步骤的协议应称为“缩短协议”。精确的语言对于确保清晰的沟通、准确的数据解释和正确的临床实践至关重要。只有物理上加速冷却或升温速率的协议才应该被贴上“快速”或“超快速”的标签。
{"title":"The new vitrification and warming protocols: when rapid is not really rapid.","authors":"Alessandro Bartolacci, Lodovico Parmegiani, Gabor Vajta","doi":"10.1016/j.rbmo.2026.105497","DOIUrl":"https://doi.org/10.1016/j.rbmo.2026.105497","url":null,"abstract":"<p><p>New vitrification and warming protocols have recently been developed to shorten procedure times and reduce exposure to potentially harmful cryoprotectants (CPA). These protocols are often described as 'rapid' or 'ultra-fast' but these terms are misleading. Speed-related terminology in cryopreservation has historically referred to cooling and warming rates, and not the length of time samples spend in solutions. Using 'rapid' warming or 'ultra-fast' vitrification implies that the speed at which a sample goes from cryogenic temperature (-196°C) to body temperature (37°C) or vice versa has been increased. However, most newly proposed protocols shorten exposure times or eliminate steps without altering thermal kinetics or CPA uptake and removal dynamics. Calling them 'rapid' causes confusion and may mislead practitioners. Instead, protocols that only reduce time in CPA solutions or omit steps should be called 'shortened protocols'. Precise language is crucial to ensure clear communication, accurate data interpretation and proper clinical practice. Only protocols that physically speed up cooling or warming rates should be labelled 'rapid' or 'ultra-fast'.</p>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"52 5","pages":"105497"},"PeriodicalIF":3.5,"publicationDate":"2026-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147513885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Reproductive biomedicine online
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1